| Active ingredient (INN) | Carbamazepine |
|---|---|
| Brand names | Epitol, Carbamazepina Zentiva |
| ATC level 5 | N03AF01 |
| ATC level 4 | N03AF |
| Therapeutic category | Auto-created by U.S. Food and Drug Administration — Drug Shortages scraper |
| WHO Essential Medicine | Yes (2023) |
| Controlled substance | No |
| Marketing-authorisation holders | Novartis Pharmaceuticals Australia Pty Ltd, MILPHARM LIMITED, MEDREICH PLC, CRESCENT PHARMA LIMITED +5 more |
| Registrations on file | 27 |
| Patient information leaflet (PIL) | Not on file |
| Summary of product characteristics (SPC) | Not on file |
| Product | Strength | Form | Market | MA holder | Status |
|---|---|---|---|---|---|
| AVLOIRE carbamazepine | 200 mg | — | 🇦🇺 AU | Novartis Pharmaceuticals Australia Pty Ltd | Active |
| AVLOIRE carbamazepine | 100 mg | — | 🇦🇺 AU | Novartis Pharmaceuticals Australia Pty Ltd | Active |
| Carbamazepine Milpharm | 200 MG | tablet | 🇬🇧 GB | MILPHARM LIMITED | Active |
| Carbamazepine Milpharm | 400 MG | tablet | 🇬🇧 GB | MILPHARM LIMITED | Active |
| Carbamazepine Medreich | 100MG | tablet | 🇬🇧 GB | MEDREICH PLC | Active |
| Carbamazepine Medreich | 200MG | tablet | 🇬🇧 GB | MEDREICH PLC | Active |
| Carbamazepine Medreich | 400MG | tablet | 🇬🇧 GB | MEDREICH PLC | Active |
| Carbamazepine Crescent | 100 MG | tablet | 🇬🇧 GB | CRESCENT PHARMA LIMITED | Active |
| Carbamazepine Crescent | 200 MG | tablet | 🇬🇧 GB | CRESCENT PHARMA LIMITED | Active |
| Carbamazepine Crescent | 400 MG | tablet | 🇬🇧 GB | CRESCENT PHARMA LIMITED | Active |
| Carbamazepine Medreich | 200 MG | tablet | 🇬🇧 GB | MEDREICH PLC | Active |
| Carbamazepine Medreich | 400 MG | tablet | 🇬🇧 GB | MEDREICH PLC | Active |
| Carbamazepine Sun | 100 MG | suspension | 🇬🇧 GB | SUN PHARMACEUTICAL INDUSTRIES EUROPE BV | Active |
| Carbamazepine Essential Pharma | 125MG | carbamazepine | 🇬🇧 GB | Essential Pharma Limited | Active |
| Carbamazepine Essential Pharma | 250MG | carbamazepine | 🇬🇧 GB | Essential Pharma Limited | Active |